| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/22/2011 | CN102100883A Preparation technology of new integrative formulation of middle regulating decoction |
| 06/22/2011 | CN102100882A Chinese medicinal composition for treating insomnia |
| 06/22/2011 | CN102100871A Chinese medicinal preparation for treating insomnia and amnesia |
| 06/22/2011 | CN102100852A Preparation technology and production method of integrated Baihu decoction novel dosage form |
| 06/22/2011 | CN102100850A Quality control method for refined fructus forsythiae antidotal tablets |
| 06/22/2011 | CN102100848A Traditional Chinese medicine composition for treating insomnia |
| 06/22/2011 | CN102100841A Wind-fixing wine and brewing method thereof |
| 06/22/2011 | CN102100813A Preparation technology of new integrative formulation of poria five powder and production method thereof |
| 06/22/2011 | CN102100809A Chinese medicine preparation for treating trigeminal neuralgia |
| 06/22/2011 | CN102100808A Chinese medicinal preparation for treating headache |
| 06/22/2011 | CN102100777A Medicinal liquor for treating stroke sequela |
| 06/22/2011 | CN102100774A Green and natural Chinese medicine powder for foot bath and health care |
| 06/22/2011 | CN102100763A Preparation technology of new integrative formulation of counterflow decoction and production method thereof |
| 06/22/2011 | CN102100756A Preparation technology of integrated rhubarb and aconite decoction novel dosage form |
| 06/22/2011 | CN102100745A Oral administration medicament for treating depression |
| 06/22/2011 | CN102100724A Method for processing eucommia ulmoides bark and preparing handicraft by eucommia ulmoides branch and root |
| 06/22/2011 | CN102100714A Method for extracting active ingredients of Echinacea through supercritical carbon dioxide |
| 06/22/2011 | CN102100698A New clinical use of pharmaceutical composition |
| 06/22/2011 | CN102100684A Application of secoisolariciresinol in preparation of medicament for treating depression and anxiety |
| 06/22/2011 | CN102100682A Slow release long-acting rasagiline transdermal patch with high bioavailability and preparation method thereof |
| 06/22/2011 | CN102100676A Vinpocetine orally disintegrating tablets |
| 06/22/2011 | CN102100660A Oral solid preparation containing venlafaxine hydrochloride and preparation method thereof |
| 06/22/2011 | CN102100459A Chinese herbal medicine bamboo charcoal healthcare mattress and preparation method thereof |
| 06/22/2011 | CN101862418B Rehabilitation capsule of drug-taking patient |
| 06/22/2011 | CN101780249B Traditional Chinese medicine composition for treating stroke hemiplegia and preparation method thereof |
| 06/22/2011 | CN101647900B Traditional Chinese medicine preparation capable of improving sleep and relaxing the bowel to relieve constipation and preparation method thereof |
| 06/22/2011 | CN101632830B Sobering-up oral liquid |
| 06/22/2011 | CN101485728B Chrysanthemum medicine pillow |
| 06/22/2011 | CN101455714B Detection method of traditional Chinese medicine composition capable of nourishing the heart to calm the mind |
| 06/22/2011 | CN101417022B Traditional Chinese medicine for treating series headache |
| 06/22/2011 | CN101366860B Jiaomei oral liquid for benefiting sleep and removing speckle |
| 06/22/2011 | CN101361918B Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 06/22/2011 | CN101317966B Medicament for treating senile dementia and preparation method thereof |
| 06/22/2011 | CN101254247B Pharmaceutical combination with depression resistance and angst resistance effect and method of preparing the same |
| 06/22/2011 | CN101006055B 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
| 06/21/2011 | US7964732 Substituted bicyclocarboxyamide compounds |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964641 administering lipid glycerides for treating neurodegenerative disease such as multiple sclerosis; increasing transforming growth factors and tumor necrosis factors |
| 06/21/2011 | US7964607 Pyrazolo[3,4-d]pyrimidine compounds |
| 06/21/2011 | US7964593 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 06/21/2011 | US7964220 Method for treating a mammal by administration of a compound having the ability to release CO |
| 06/21/2011 | US7964199 Therapeutic composition comprising a botulinum neurotoxin |
| 06/21/2011 | US7964192 Prevention and treatment of amyloidgenic disease |
| 06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2454047C Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 06/21/2011 | CA2442114C N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 06/21/2011 | CA2431011C Compositions and methods of use for extracts of magnoliaceae plants |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2303460C Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors |
| 06/21/2011 | CA2299442C Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 06/18/2011 | CA2724086A1 Pharmaceutical compounds |
| 06/16/2011 | WO2011072257A2 Amyloid binding agents |
| 06/16/2011 | WO2011072207A1 Azocyclic inhibitors of fatty acid amide hydrolase |
| 06/16/2011 | WO2011071996A1 Faah inhibitors |
| 06/16/2011 | WO2011071920A2 Promoting cycling of apoe4 isoform |
| 06/16/2011 | WO2011071805A1 4-methylpyrazole formulations |
| 06/16/2011 | WO2011071758A1 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands |
| 06/16/2011 | WO2011071135A1 Oxazine derivative |
| 06/16/2011 | WO2011071109A1 Fused heterocyclic compound having amino group |
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011071057A1 Pharmaceutical composition for treatment or prevention of alzheimer's disease containing sulfur-containing heterocyclic derivative |
| 06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |
| 06/16/2011 | WO2011070781A1 Substituted aminothiazine derivative |
| 06/16/2011 | WO2011070444A2 Compositions and methods for treating friedreich's ataxia |
| 06/16/2011 | WO2011070253A1 Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same |
| 06/16/2011 | WO2011070252A1 Azabicyclo[3.2.0]hept-6-yl derivatives as antagonists of histamine h3 receptor |
| 06/16/2011 | WO2011070251A1 Novel hexahydrocyclopenta[b]pyrrol derivatives, method for preparing same, and pharmaceutical compositions containing same |
| 06/16/2011 | WO2011070250A1 Novel azabicyclo[3.2.0]hept-3-yl derivatives, method for preparing same, and pharmaceutical compositions containing same |
| 06/16/2011 | WO2011070177A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/16/2011 | WO2011069951A1 Imidazolidinedione derivatives |
| 06/16/2011 | WO2011069944A1 Crystalline {(3s)-3-[({1-[(2r)-2-carboxy-4-(1-naphthyl)butyl]cyclopentyl}-carbonyl)amino]-2-oxo-2,3,4,5-tetrahydro-1h-1benzazepin-1-yl}acetic acid, its preparation and use |
| 06/16/2011 | WO2011069335A1 Use of pyridines compounds in preparing rna interference reinforcing agent |
| 06/16/2011 | WO2011069334A1 Cdk5 inhibitors and therapeutic uses thereof |
| 06/16/2011 | WO2011069294A1 N6-substituted adenosine derivatives, n6-substituted adenine derivatives and uses thereof |
| 06/16/2011 | WO2011049948A3 Neuroprotection and myelin repair using nestorone® |
| 06/16/2011 | WO2011047770A3 Pyrazolopyrimidine derivatives |
| 06/16/2011 | WO2011042872A4 Use of a dna replication inhibitor for treating neurodegenerative diseases caused by polyglutamine expansion |
| 06/16/2011 | WO2011041731A3 Method of inhibiting bcl-2-related survival proteins |
| 06/16/2011 | WO2011039554A3 2,3,4-benzothiadiazepine-2,2-dioxide derivatives |
| 06/16/2011 | WO2011022462A3 Neural regeneration |
| 06/16/2011 | WO2011020061A3 Compositions and methods of for treating bipolar disorder |
| 06/16/2011 | WO2011019821A3 METHOD FOR MAKING 3α-HYDROXY, 3β- METHYL-5α-PREGNAN-20-ONE (GANAXOLONE) |
| 06/16/2011 | WO2011017600A3 Compositions and methods for treating beta-amyloid related diseases |
| 06/16/2011 | WO2011014475A3 Treating negative symptoms of schizophrenia associated with defective neuregulin 1 |
| 06/16/2011 | WO2011011420A3 3, 4-methylenedioxyphenyl inhibitors of gaba aminotransferase and/or gaba reuptake transporter inhibitor |
| 06/16/2011 | WO2011008298A3 Novel axomadol dosage forms |
| 06/16/2011 | US20110145941 Antibodies and derivatives thereof |
| 06/16/2011 | US20110145938 Method for generating monoclonal antibodies that recognize progenitor cells |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144210 Stable dosage forms of levomilnacipran |
| 06/16/2011 | US20110144206 Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity |